InvestSMART

Montaka Global Extension Fund (Quoted Managed Hedge Fund) (ASX: MKAX) - Announcements

- Current share price for MKAX : $2.950

Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX) is a global equities manager with offices in Sydney, Melbourne and New York. The Fund seeks to invest in a portfolio of global equities listed on major global exchanges purchased at a discount to the estimate of intrinsic value.

Latest company announcements for Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$67 MKAX April 2023 Monthly Report 9 May 2023 11:46AM $2.340 $2.950 risen by 26.07%
$67 MKAX - Monthly Redemption and Units on Issue - April 23 4 May 2023 2:44PM $2.370 $2.950 risen by 24.47%
$67 MKAX - Monthly Prime Brokerage Disclosure - April 23 3 May 2023 4:12PM $2.410 $2.950 risen by 22.41%
$67 MKAX March 2023 Monthly Report 12 Apr 2023 4:38PM $2.440 $2.950 risen by 20.90%
$67 MKAX - Monthly Redemption and Units on Issue - March 23 11 Apr 2023 12:27PM $2.440 $2.950 risen by 20.90%
$67 MKAX - Monthly Prime Brokerage Disclosure - March 23 5 Apr 2023 1:42PM $2.440 $2.950 risen by 20.90%
$67 MKAX February 2023 Monthly Report 10 Mar 2023 3:51PM $2.350 $2.950 risen by 25.53%
$67 MKAX - Financial Statements HY 31 Dec 22 8 Mar 2023 9:10AM $2.330 $2.950 risen by 26.61%
$67 MKAX - Monthly Redemption and Units on Issue - Feb 23 7 Mar 2023 1:54PM $2.330 $2.950 risen by 26.61%
$67 MKAX - Monthly Prime Brokerage Disclosure - 28 Feb 23 6 Mar 2023 12:02PM $2.310 $2.950 risen by 27.71%
$67 Updated MKAX Quarterly Portfolio Disclosure - 31 Dec 22 23 Feb 2023 9:13AM $2.270 $2.950 risen by 29.96%
$67 MKAX Quarterly Portfolio Disclosure - 31 Dec 22 22 Feb 2023 11:35AM $2.400 $2.950 risen by 22.92%
$67 MKAX Investment Report January 2023 8 Feb 2023 10:18AM $2.430 $2.950 risen by 21.40%
$67 MKAX - Monthly Prime Brokerage Disclosure - Jan 23 6 Feb 2023 3:28PM $2.430 $2.950 risen by 21.40%
$67 MKAX - Monthly Redemption and Units on Issue - Jan 23 6 Feb 2023 1:50PM $2.430 $2.950 risen by 21.40%
$67 MKAX Investment Report December 2022 17 Jan 2023 4:08PM $2.030 $2.950 risen by 45.32%
$67 Final MKAX - Distribution - 31 Dec 22 12 Jan 2023 11:05AM $2.030 $2.950 risen by 45.32%
$67 MKAX - Monthly Redemption and Units on Issue - Dec 22 9 Jan 2023 12:50PM $2.000 $2.950 risen by 47.50%
$67 MKAX - Monthly Prime Brokerage Disclosure - Dec 22 9 Jan 2023 12:48PM $2.000 $2.950 risen by 47.50%
$67 MKAX - Pause in Trading to be lifted 21 Dec 2022 11:58AM $2.000 $2.950 risen by 47.50%
$67 Pause in Trade 21 Dec 2022 11:23AM $2.000 $2.950 risen by 47.50%
$67 MKAX - Estimated Distribution - 31 Dec 2022 14 Dec 2022 3:23PM $2.150 $2.950 risen by 37.21%
$67 MKAX Investment Report November 2022 9 Dec 2022 12:27PM $2.170 $2.950 risen by 35.94%
$67 MKAX - Monthly Redemption and Units on Issue - Nov 22 7 Dec 2022 3:57PM $2.170 $2.950 risen by 35.94%
$67 MKAX - Prime Brokerage Disclosure - Nov 2022 7 Dec 2022 11:56AM $2.170 $2.950 risen by 35.94%

151 - 175 of 279 results

Page 7 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.